The University of Maryland School of Pharmacy and the University of Maryland Medical Center offer a one-year post-graduate residency training experience in infectious diseases pharmacy practice.
PGY2 pharmacy residency programs build on Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.
The goals of this program is to impart the knowledge and skills necessary for obtaining a position as a clinical pharmacy specialist or non-tenure track faculty member in the area of antimicrobial stewardship and infectious diseases pharmacy practice. Through the unique partnership between the University of Maryland School of Pharmacy and University of Maryland Medical Center, the resident will interface with experts in the field of infectious diseases, engage in a diverse array of advanced pharmacy practice experiences, conduct collaborative practice-based research, and mentor student and resident trainees in pharmacy and other health disciplines.
Because this residency program is accredited by the American Society of Health-System Pharmacists (ASHP), the resident will complete the following ASHP-established outcomes:
- Promote health improvement, wellness, and the prevention of infectious diseases.
- Optimize the outcomes of individuals with an infectious disease by providing evidence-based, patient-centered medication therapy as an integral member of an interdisciplinary team or as an independent clinician.
- Manage and improve anti-infective-use processes.
- Demonstrate excellence in the provision of educational activities for health care professionals and health care professionals in training centering on optimizing anti-infective pharmacotherapy.
- Serve as an authoritative resource on the optimal use of medications used to treat individuals with an infectious disease.
- Demonstrate leadership and practice management skills.
- Conduct infectious diseases pharmacy practice research.
Additionally, our program adheres to the Goals and Objectives for a Post-Graduate Year Two Program in Infectious Diseases set forth by ASHP. These Goals and Objectives can be found in the ASHP Residency Accreditation Regulations and Standards.
The University of Maryland Medical Center (UMMC) will serve as the primary site for pharmacy practice experiences. Located in downtown Baltimore, UMMC was one of the nation's first academic medical centers. Today it provides a diverse array of health care services to patients throughout Maryland and the Mid-Atlantic region including a large solid organ transplant program, a comprehensive cancer center with a bone marrow transplant unit, a dedicated HIV medicine service and the R. Adams Cowley Shock Trauma Center. The integrated approach to patient care, research, and education at UMMC and the University of Maryland School of Pharmacy provides a unique opportunity to engage in an innovative training experience that may be individually tailored to the interests and goals of the resident.
The residency program consists of approximately nine months of core experiences and three months of electives. Longitudinal experiences are also required.
|Core Rotation Experiences|
|Orientation & Training||4 weeks|
|Antimicrobial Stewardship I||4 weeks|
|Infectious Diseases Consults I (General)
|Infectious Diseases Consults II (Critically Ill)
|Infectious Diseases Consults III (Immunocompromised)
|Inpatient Infectious Diseases Medicine Service||4 weeks|
|Clinical/Outcomes Research||4 weeks|
|Clinical Pharmacy Specialist/Preceptorship||4 weeks|
|Microbiology Laboratory||2 weeks|
|Core Longitudinal Experiences|
|Antimicrobial Stewardship II||6 months|
|Infectious Diseases Literature/Topic Curriculum||12 months|
|HIV/HCV Clinic||6 months|
|Clinical and Operational Staffing||12 months|
|Elective Practice Experiences (3 months)*|
|Community Hospital Antimicrobial Stewardship||2-4 weeks|
|Surgical Intensive Care Unit||2-4 weeks|
|Pediatric Infectious Diseases Consults||2-4 weeks|
|Global Health/Tropical Diseases||3 weeks|
*Any of the ID consult services can be repeated or extended as an elective. Other electives can be arranged based on the resident’s interest.
Other Learning Experiences:
In addition to the pharmacy practice experiences outlined above, the resident will also have the opportunity to participate in the following longitudinal learning experiences:
The resident will earn an appointment as a clinical instructor at the University of Maryland School of Pharmacy and will complete a total of 40 hours of teaching activities per semester. Teaching activities may include didactic lectures, small group discussions, skills laboratories, and assisting in the preceptorship of student pharmacists and first-year pharmacy practice residents. An elective teaching certificate program is available for interested residents.
Residents will also deliver the following professional presentations:
- Pharmacotherapy Rounds
- UMMC Journal Club
- UMMC Case Conference
The resident will be expected to conduct a longitudinal research project over the course of the training experience. A final manuscript of the project must be completed and submitted for publication, although acceptance is not required. Presentation of interim or final results at a professional meeting is strongly encouraged.
The resident will also be expected to be involved in at least one additional scholarly activity. Examples include publication of a clinical review in a peer-reviewed journal or professional newsletter or a poster presentation at a regional or national meeting.
Finally, the resident will be required to complete a medication use evaluation at UMMC in the area of antimicrobial stewardship.
Leadership & Professional Development Experiences
The resident will also participate in the following longitudinal activities:
- UMMC Committee Participation
- Professional Development Series
- Public Health/Community Service Activity
Participation in Pharmacotherapy Rounds, Journal Club, Case Conference, Professional Development lecture series, and staffing responsibilities is a requirement of all University of Maryland residents. For more information about these specific activities, please visit the Residency & Fellowship Requirements webpage.
- Emily Heil, PharmD, BCIDP, BCPS-AQ ID, AAHIVP (Antimicrobial Stewardship, Inpatient Infectious Diseases Service, ID Consults)
- Kimberly Claeys, PharmD, BCPS (Antimicrobial Stewardship, ID Consults)
- Mary Banoub, PharmD, BCIDP (Antimicrobial Stewardship, Inpatient Infectious Diseases Service, ID Consults)
- Neha Sheth Pandit, PharmD, BPCS, AAHIVP (HIV/HCV Clinic)
- Lauren Hynicka, PharmD, BCPS (HCV Clinic)
- Jennifer Bailey, PharmD, BCPS, AAHIVP (Inpatient Infectious Diseases Service)
Number of Available Positions: 1
Qualifications: The resident must be a graduate of an accredited college of pharmacy with a minimum GPA of 3.0 (requirement waived if completed a pass/fail curriculum). The Doctor of Pharmacy (PharmD) degree and Maryland Pharmacy licensure are required. Residents must complete a PGY1 residency prior to starting.
Applicants must possess a Doctor of Pharmacy degree and have completed an ASHP-accredited residency in pharmacy practice. The resident will be required to become a licensed pharmacist in the state of Maryland.
Applications for this program will only be accepted through PhORCAS. Reference writers should use the standard reference template in PhORCAS.
- Letter of intent
- Curriculum vitae
- Letters of recommendation (3)
- Official transcripts
International students and permanent residents should contact email@example.com before applying.
Residents who match to this program will be required to come to Baltimore in advance of the July 1 start date for campus orientation; these orientation dates are not known until mid-Spring. These sessions are typically offered on select Mondays in May and June.
The application deadline is January 1.
Emily Heil, PharmD, BCIDP, BCPS-AQ ID, AAHIVP
Associate Professor, Infectious Diseases
Department of Pharmacy Practice & Science
University of Maryland School of Pharmacy
20 N Pine Street, Room N413
Baltimore, MD 21201